APA (7th ed.) Citation

Eikelboom, J. W., Hirsh, J., Weitz, J. I., Johnston, M., Yi, Q., & Yusuf, S. (2002). Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events. Circulation (New York, N.Y.), 105(14), 1650-1655. https://doi.org/10.1161/01.CIR.0000013777.21160.07

Chicago Style (17th ed.) Citation

Eikelboom, John W., Jack Hirsh, Jeffrey I. Weitz, Marilyn Johnston, Qilong Yi, and Salim Yusuf. "Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events." Circulation (New York, N.Y.) 105, no. 14 (2002): 1650-1655. https://doi.org/10.1161/01.CIR.0000013777.21160.07.

MLA (9th ed.) Citation

Eikelboom, John W., et al. "Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events." Circulation (New York, N.Y.), vol. 105, no. 14, 2002, pp. 1650-1655, https://doi.org/10.1161/01.CIR.0000013777.21160.07.